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ABSTRACT 49 
 50 
PURPOSE: To compare the visual, refractive and adverse outcomes of femtosecond 51 
laser-assisted cataract surgery (FLACS) to conventional phacoemulsification 52 
cataract surgery (CPCS). 53 
 54 
SETTING: Cataract surgery clinics in 9 European countries and Australia (FLACS) 55 
and in 18 European countries and Australia (CPCS). 56 
 57 
DESIGN: Multicenter consecutive case control study from the European Registry of 58 
Quality Outcomes for Cataract and Refractive Surgery. 59 
 60 
METHODS: Eyes undergoing FLACS were matched to eyes undergoing CPCS, for 61 
preoperative corrected distance visual acuity (CDVA), age and preoperative risk 62 
factors. The two groups were compared for intraoperative and postoperative 63 
complications, postoperative CDVA, absolute biometry prediction error (BPE), 64 
 4 
preoperative and postoperative corneal astigmatism and surgically induced 65 
astigmatism (SIA). Follow-up was 7-60 days.  66 
 67 
RESULTS: A total of 2,814 FLACS cases were matched to 4,987 CPCS cases. The 68 
majority were female (57%) with mean age 66 years and baseline logMAR CDVA 69 
0.32 (6/12-1). Posterior capsule complications were similar (FLACS: 0.4 %; CPCS: 70 
0.7%). Postoperative logMAR CDVA differed by one letter (FLACS: 0.05 [6/6-3]; 71 
CPCS: 0.03 [6/6-2]). At follow-up, FLACS versus CPCS compared as follows: worse 72 
postoperative CDVA (by 5 letters or more): 1% versus 0.4%; % CDVA 0.3 (6/12) or 73 
better: 87.8% versus 90.4% ; absolute BPE: 0.43 D versus 0.40 D; % within ± 0.5D 74 
of target: 72% versus 74.3%;  postoperative complications : 3.4% versus 2.3%.  75 
 76 
CONCLUSION: FLACS does not have superior visual and refractive outcomes, but 77 
does have superior corneal astigmatic treatment outcomes, compared to CPCS. 78 
Intraoperative complications are similar and low in both groups. Postoperative 79 
complications are lower in CPCS. 80 
 81 
 82 
 83 
  84 
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 INTRODUCTION 85 
 86 
Femtosecond laser-assisted cataract surgery (FLACS) has been under the spotlight 87 
since the first publication of its use in clinical practice, in 2009. (Nagy 2009) 88 
Femtosecond lasers can perform the anterior capsulotomy, lens fragmentation and 89 
corneal incision construction, as well as corneal astigmatic treatment  90 
 91 
There has been significant excitement in the peer-reviewed (Mamalis 2013; 92 
Lindstrom 2011) and non-peer-reviewed (Duke Med Health News Nov 13; Duke 93 
Med Health News Jan 2012) ophthalmic literature, regarding the potential 94 
advantages of FLACS over conventional phacoemulsification cataract surgery 95 
(CPCS).  96 
 97 
Successful outcome in cataract surgery is measured in terms of visual outcome 98 
(visual acuity) (Lundstrom 2012; Jaycock 2009; Hahn 2011), refractive outcome 99 
(biometry prediction error [BPE] of postoperative refraction) (Lundstrom 2012; 100 
Hahn 2011), rate of complications (with the rate of torn posterior capsule being used 101 
as a benchmark standard against which cataract surgeons measure 102 
themselves)(Lundstrom 2012; Johnston 2010) and, more recently, patient-reported 103 
outcome measures (PROMs). (McAlinden 2011; Lamoureux 2011) 104 
 105 
Even though several studies have shown that FLACS demonstrates better 106 
reproducibility in terms of capsulotomy diameter and centration (Nagy 2011; 107 
Friedman 2011; Kranitz 2011; Auffarth 2013; Reddy 2013; Mastropasqua 2013), 108 
corneal wound construction (Mastropasqua 2014; Grewal 2014) and decreased 109 
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ultrasound energy and time (Takacs 2012; Conrad-Hengerer 2012 a; Abell 2013; 110 
Conrad-Hengerer 2013 c; Reddy 2013; Daya 2014), there is no evidence, to date, 111 
showing that visual and refractive outcomes achieved with FLACS, are superior, in a 112 
clinically meaningful way, to those achieved with CPCS. (Kránitz 2012; Miháltz 113 
2011; Abell 2013; Roberts 2012; Lawless 2012; Filkorn 2012)   114 
 115 
In addition, even though posterior capsule complication rates with FLACS are 116 
reported as similar to the lowest published rates for CPCS (Roberts 2013), these 117 
findings need to be balanced against the fact that these FLACS studies excluded 118 
cases with small pupil and other difficult cases, which carry a higher risk of posterior 119 
capsule rupture. 120 
 121 
So, even though there is a plethora of published reports about FLACS in the 122 
literature, there is lack of evidence regarding its superiority over CPCS. The authors 123 
believe such evidence can be delivered by a carefully constructed case-control 124 
study, using the European Registry of Quality Outcomes for Cataract and Refractive 125 
Surgery (EUREQUO), a well-established multinational cataract and refractive 126 
surgery database. EUREQUO has contributed to the formulation of evidence-based 127 
guidelines for CPCS (Lundström 2012) and has provided data on visual outcomes  128 
in a real-life clinical setting. (Lundström 2013) 129 
 130 
The superiority of FLACS over CPCS, has not been shown. This study aims to 131 
compare the visual, refractive and adverse outcomes of a consecutive series of 132 
FLACS cases to carefully matched cases of CPCS as reported in EUREQUO.  133 
 134 
MATERIALS AND METHODS 135 
 7 
 136 
Ophthalmic surgeons from Europe and Australia, with known clinical experience in 137 
FLACS, were invited, to participate in the study. The laser platform was not identified 138 
in order to avoid bias. The surgeons had to have performed at least 50 cases of 139 
FLACS to account for the learning curve associated with a new procedure. The 140 
FLACS cases reported had to be consecutive and a case was included from the 141 
moment docking was attempted.  142 
 143 
The EUREQUO web form was used as the case report form for all cases. The 144 
patients were informed about registration of their data in EUREQUO and were free to 145 
accept or refuse participation in the study, without their decision affecting their 146 
treatment. A dedicated, site-specific, registry manager, trained by the European 147 
Society of Cataract and Refractive Surgeons, ensured that reporting guidelines were 148 
met and consecutive FLACS cases were reported. Local institutional ethics 149 
committee approval was obtained for each participating clinic.   150 
 151 
The EUREQUO web form normally used for recording CPCS preoperative, 152 
intraoperative and postoperative data underwent expansion, to allow recording of 153 
parameters specific to FLACS. (Lundstrom 2012) A number of FLACS-specific 154 
parameters were extracted for each FLACS case, in addition to the regular 155 
parameters related to CPCS:  156 
 157 
Demographic data: age; gender. 158 
 159 
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Preoperative data: corrected distance visual acuity (CDVA) in logarithm of the 160 
minimum angle of resolution (logMAR) (calculated from the decimal notation in the 161 
database) [with Snellen equivalent]; target refraction [D]; keratometry (K) readings; 162 
ocular co-morbidity (glaucoma; AMD; diabetic retinopathy; amblyopia; other); 163 
surgical difficulty (previous corneal refractive surgery; white cataract; 164 
pseudoexfoliation; previous vitrectomy; corneal opacity; small pupil; other). 165 
 166 
Intra operative data: steps of the cataract operation for which the laser platform was 167 
used (corneal incision, corneal astigmatic treatment, capsulotomy, nucleus 168 
fragmentation); type of intraocular lens (IOL) (acrylic hydrophilic; acrylic hydrophobic; 169 
hydrogel; PMMA; silicone; no IOL); additional IOL specification (accommodative; 170 
toric; multifocal; multifocal toric); surgical complications common to both procedures 171 
(torn posterior capsule; vitreous loss; iris damage; dropped nucleus; other); FLACS-172 
specific complications (procedure abandoned and reason, conversion to CPCS or 173 
extracapsular cataract extraction, incision-related complications, capsulotomy-174 
related complications, lens fragmentation-related complications, other laser-related 175 
complications).  176 
 177 
Postoperative data: CDVA in logMAR (calculated from the decimal notation in the 178 
database) [with Snellen equivalent]; K-readings; postoperative refraction; 179 
postoperative complications (uveitis; corneal edema; early posterior capsule 180 
opacification; uncontrolled intraocular pressure; IOL explantation; other). 181 
 182 
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FLACS cases were recruited between December 1st 2013 and May 31st 2015. 183 
CPCS cases were recruited retrospectively from the CPCS cases reported in the 184 
EUREQUO database in 2014.  185 
 186 
Statistical analysis 187 
 188 
The criteria for matching CPCS cases to FLACS cases included: exact matching for 189 
preoperative logMAR CDVA in the eye to be operated on; age matched within 2 190 
years; same number of ocular co-morbidities (see preoperative data); same number 191 
of surgical difficulty variables (see preoperative data). We aimed to match two CPCS 192 
cases for each FLACS case.  193 
 194 
All statistical calculations were performed using IBM SPSS, version 22, IBM Ltd, 195 
Chicago, Ill. Demographic data were analyzed using descriptive statistics. CPCS 196 
cases were compared to FLACS cases for age, gender, preoperative and 197 
postoperative CDVA, intraoperative and postoperative complications, absolute 198 
biometry prediction error (BPE), preoperative and postoperative corneal astigmatism 199 
and surgically induced astigmatism (SIA) by Naeser polar value. The chi-square test 200 
was used for categorical variables and the 2-tail 6WXGHQW¶V t-test for numerical 201 
variables. 202 
 203 
Unchanged postoperative CDVA was defined as postoperative CDVA within 0.10 204 
logMAR of preoperative CDVA, according to Bailey et al. (Bailey 1991) (1 Snellen 205 
line of 5 letters). Accordingly, better postoperative CDVA was defined as CDVA that 206 
had increased by more than 0.10 logMAR from the preoperative value and worse 207 
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postoperative CDVA was defined as CDVA that had deteriorated by more than 0.10 208 
logMAR from the preoperative value. The percentage of CPCS and FLACS cases 209 
with better, unchanged and worse postoperative CDVA were examined as was the 210 
percentage of CPCS and FLACS cases with BPE within ± 0.5 D and within ± 1.0 D of 211 
target. Follow up period in the database ends 2 months after surgery. Multivariate 212 
analyses of relationships between the dichotomized visual outcome and the other 213 
variables were performed by logistic regression.  214 
 215 
Refractive surprise was defined as a BPE outside ± 2 D of target. Corneal 216 
astigmatism [mean K] was defined as [mean Ksteep] - [mean Kflat], both before and 217 
after surgery. Clinically significant residual postoperative corneal astigmatism was 218 
defined as corneal astigmatism  1.5 D. Multivariate analyses of relationships 219 
between postoperative corneal astigmatism and other variables were performed by 220 
logistic regression. Multivariate analyses of relationships between SIA and other 221 
variables were performed by linear regression.  In all analyses, a p-value of 0.05 or 222 
less was considered significant.  223 
 224 
RESULTS 225 
 226 
Surgeons from 10 countries (Australia; Belgium; Czech Republic; Germany; 227 
Hungary; Italy; the Netherlands; Spain; Turkey; United Kingdom) contributed data 228 
from FLACS cases, between December 2013 and May 2015. Surgeons from 19 229 
countries (Australia; Austria; Belgium; Czech Republic; Denmark; Germany; Greece; 230 
Hungary; Iceland; Ireland; Italy; Lithuania; the Netherlands; Norway; Slovak 231 
Republic; Spain; Switzerland; Turkey, United Kingdom) contributed data from CPCS 232 
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cases, between January and December 2014. The number of FLACS cases and 233 
matched CPCS controls are given in Figure 1. The achieved 1:1.8 case-control ratio 234 
did not reach the intended 1:2 case-control ratio. The preoperative characteristics of 235 
the two groups are given in Table 1. 236 
 237 
In the 2,814 FLACS cases with matched CPCS controls, a femtosecond laser was 238 
used to carry out the corneal incisions in 34.7% of cases, the capsulotomy in 99.4% 239 
of cases and the nucleus fragmentation in 94.7% of cases. In addition, 4.5% of 240 
FLACS cases had corneal astigmatism treated by the femtosecond laser at the time 241 
of cataract surgery. 242 
 243 
Intra operative complications of FLACS and CPCS are given in Table 2. FLACS-244 
specific complications are given in Table 3. Data on type of IOL implanted are given 245 
in Table 4. 246 
 247 
Postoperative outcomes, including visual outcomes, refractive outcomes and 248 
postoperative complications, are given in Table 5, for all FLACS cases compared to 249 
all CPCS cases. Due to the high rate of use of multifocal IOLs in the FLACS group 250 
(see Table 4), we compared postoperative outcomes between FLACS cases and 251 
CPCS cases, including only cases where monofocal IOLs were used.  252 
 253 
Multivariate logistic regression analysis results for the association between worse 254 
postoperative CDVA after FLACS or CPCS and significant preoperative, 255 
intraoperative and postoperative variables, are reported in Table 6A for monofocal 256 
IOLs only and in table 6B for all cases. Multivariate logistic regression analysis 257 
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results for the association between refractive outcome of FLACS or CPCS and 258 
significant preoperative and intraoperative variables are reported in Table 7. 259 
Multivariate logistic regression analysis results for the association between 260 
postoperative corneal astigmatism after FLACS or CPCS and significant 261 
preoperative and intraoperative variables are reported in Table 8.  262 
 263 
In a multivariate linear regression analysis for the association between postoperative 264 
SIA (reported by the Naeser polar value) after FLACS or CPCS and significant 265 
preoperative and intraoperative variables, a higher Naeser polar value was predicted 266 
(standardized beta coefficient [CI]) by poorer preoperative logMAR CDVA (0.69 267 
[0.114 ± 0.224]), previous astigmatic treatment (0.71 [0.207 ± 0.406]), any ocular co-268 
morbidity (0.52 [0.068 ± 0.169]), CPCS (0.061 [0.069 ± 0.155]), previous corneal 269 
refractive surgery (0.58 [0.262 ± 0.587]) and female gender (0.028 [0.11 ± 0.091]).  270 
 271 
DISCUSSION 272 
 273 
The intention of this study was to compare FLACS to CPCS, in terms of visual 274 
outcome, refractive outcome and complications, by means of a case-control study 275 
using data from EUREQUO. 276 
 277 
The intended 1:2 case-control ratio was not achieved despite the large number of 278 
CPCS cases submitted to EUREQUO during the study period (over 295,000 cases), 279 
because there were not enough CPCS controls in the database with matching 280 
preoperative CDVA and matching (young) age. The trend for FLACS patients to 281 
have better preoperative CDVA has been reported before (Ewe 2015) and may 282 
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indicate surgeon or patient preference for FLACS, or possibly, socioeconomic 283 
influences on the selected mode of surgery. The trend for younger age in FLACS, 284 
compared to CPCS patients, which was overcome with meticulous matching, has not 285 
been reported in previous comparative studies. (Abell 2013; Abell 2014; Mayer 286 
2014b; Ewe 2015). However, age may be a confounding factor for other 287 
characteristics in the FLACS group, such as previous corneal refractive surgery and 288 
preference for non-monofocal IOLs.  289 
 290 
There was a difference in the type of detailed? ocular co-morbidities and surgical 291 
difficulty variables between the two groups. There were more patients with diabetic 292 
retinopathy in the CPCS than the FLACS group and more patients with amblyopia in 293 
the FLACS than the CPCS group. Other studies comparing FLACS to CPCS either 294 
excluded patients with coexistent ocular disease (Conrad-Hengerer 2015) or did not 295 
report preoperative ocular co-morbidities. (Ewe 2015). In one study where patients 296 
with ocular co-morbidities, other than corneal were included, the preoperative and 297 
postoperative CDVA did not differ in the two groups. (Abell 2013). The difference in 298 
diabetic retinopathy rates in this study may indicate surgeon preference for eyes with 299 
less disease for the newer surgical technique, while the difference in amblyopia rates 300 
may indicate surgeon preference for eyes with a wider visual safety margin for the 301 
newer surgical technique. The FLACS group had a much higher rate of previous 302 
corneal refractive surgery and pseudoexfoliation, while the CPCS group had a much 303 
higher rate of white cataracts, small pupils and other surgical difficulty variables 304 
(such as deep-set eyes, patients with kyphosis or other inability to position for 305 
surgery etc). 306 
 307 
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The higher rate of previous corneal refractive surgery in the FLACS group is, 308 
clinically, very significant. A recent study showed that CPCS patients with previous 309 
corneal refractive surgery are younger and at much higher risk of worse 310 
postoperative CDVA than patients without previous corneal refractive surgery, 311 
especially when they have good preoperative CDVA. (Manning 2015) Studies 312 
comparing FLACS to CPCS to date, either excluded patients with previous corneal 313 
refractive surgery (Abell 2013) or did not report on that preoperative characteristic. 314 
(Ewe 2015) It is possible that FLACS surgeons also perform corneal refractive 315 
surgery, so they have an over representation of patients with previous corneal 316 
refractive surgery, who subsequently undergo cataract surgery.  317 
 318 
There were more white cataracts in the CPCS than in the FLACS group. This is likely 319 
because laser is unable to penetrate through opaque lens material, so that the laser 320 
cannot perform the step of lens fragmentation. Also, even though anterior 321 
capsulotomy in white cataracts is technically feasible with FLACS, the rate of 322 
capsule related complications such as radial tears, capsular tags and incomplete 323 
capsulotomy buttons, is still high in such cases. (Conrad-Hengerer 2014) 324 
 325 
The rate of pseudoexfoliation was higher in the FLACS compared to the CPCS 326 
group. However, the two groups were not matched for race. In addition, there can be 327 
up to 50% clinical under-diagnosis of pseudoexfoliation, according to a 328 
histopathologic study of 40 eyes with late in-the-bag subluxation or dislocation. (Liu 329 
2015) 330 
 331 
In contrast, the rate of small pupils was higher in the CPCS compared to the FLACS 332 
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group. This is because laser capsulotomy requires direct line of site to the capsule 333 
and a safety zone of 1000 µm between iris and capsule to avoid inadvertent laser 334 
damage to the iris and subsequent intraoperative pupil miosis. Techniques to assist 335 
FLACS in eyes with a small pupil have been described. (Conrad-Hengerer 2013) 336 
However, in such cases, it is recommended that both the FLACS treatment and the 337 
manual part of the cataract operation be performed in the same sterile room, without 338 
moving the patient, to reduce the risk of infection. This may limit the use of FLACS in 339 
eyes with small pupils to surgeons with access to that particular operating theatre 340 
arrangement. The particular operating theatre organization of each participating 341 
FLACS clinic in this study is not known. However, there were no cases of 342 
postoperative endophthalmitis in either study group. 343 
 344 
Other surgical difficulty variables, not specified in the EUREQUO database, but 345 
grouped under the term ³RWKHU´ were higher in the CPCS than in the FLACS group. 346 
The reason could be that FLACS surgeons avoid these cases as they affect the 347 
ability to obtain successful docking, such as narrow palpebral fissure, deep set orbit, 348 
severe blepharospasm, pterygia and conjunctival chalasis, or variables that affect 349 
the ability to position the patient underneath the laser, such as cervical kyphosis and 350 
inability of the patient to stay still. 351 
 352 
The laser was used for the capsulotomy in over 99% of FLACS cases, for nucleus 353 
fragmentation in 95% of cases, for corneal incisions in 35% of cases and for 354 
astigmatic incisions in 5% of cases. This breakdown is different from the results of 355 
the most recent ESCRS and ASCRS PHPEHUV¶ survey, where astigmatic incisions 356 
were used in over 70% of cases. (Duffey 2015) It may also reflect the steps of 357 
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CPCS which surgeons find more challenging (Travella 2011), or the steps during 358 
which cataract surgeons are more likely to encounter posterior capsule rupture 359 
(nuclear dismantling, and cortical aspiration) and which they would, therefore, like to 360 
be automated.  361 
 362 
Overall, the rate of complications was higher in FLACS than in CPCS cases. 363 
However, there are a number of FLACS-specific minor complications, such as 364 
imperforate corneal incisions, capsular tags and bridges and incomplete laser 365 
capsulotomies, which cannot occur during CPCS cataract surgery. This explains the 366 
higher overall rate of complications with FLACS. For this reason, during the analysis 367 
we also excluded FLACS-specific complications and we compared the rate of torn 368 
posterior capsule, with or without vitreous loss, with or without dropped nucleus 369 
(complications which are likely to affect the visual and refractive outcome) in the two 370 
groups. The rates of these complications were low and similar in both groups. Also 371 
they were similar to other large series of CPCS (Lundstrom 2012, Sparrow 2011) 372 
and FLACS (Roberts 2013, Chee 2015) cases.  373 
 374 
The rate of FLACS-specific complications was 2%. This included complications that 375 
are unlikely to affect the final visual and refractive outcomes of the surgery 376 
(imperforate corneal incisions, capsular tags and bridges and incomplete 377 
capsulotomies), but are more likely to lengthen the surgery a little, because they 378 
require the surgeon to manually complete those steps not fully completed by the 379 
laser. The concern that FLACS is more time-consuming than CPCS and may affect 380 
patient flow and volumes has been previously expressed. (Feldman 2015, Hatch 381 
2013, Donaldson 2013, Lubahn 2014) 382 
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 383 
The rate of use of non-monofocal IOLs was much higher in the FLACS than in the 384 
CPCS group. The choice of IOL to be implanted was at the discretion of the surgeon, 385 
in consultation with the patient, according to the routines of each participating clinic. 386 
High rates of non-monofocal IOL implantation in FLACS have been reported before 387 
(Ewe 2015), while some studies have found similar, albeit high rates of non-388 
monofocal IOL use in both FLACS and CPCS cases. (Chee 2015) This may suggest 389 
that FLACS patients have different preconceptions, demands and expectations from 390 
their cataract surgery than CPCS patients and may be being treated in a different 391 
healthcare system.  392 
 393 
Improvement in CDVA was defined as a gain of more than 0.1 logMAR (one line or 5 394 
letters on the chart) and deterioration as loss of more than 0.1 logMAR. These 395 
definitions were used in order to ensure that clinically meaningful changes in CDVA 396 
were captured. A meta-analysis of 9 randomized controlled trials comparing FLACS 397 
to CPCS found that CDVA was better in the FLACS group, but only by one logMAR 398 
letter. (Chen 2015) Similarly, a non-randomized cohort study of 1105 FLACS eyes 399 
with 410 matched historical controls, found that UDVA was better in the FLACS 400 
group, but by less than one logMAR letter. (Chee 2015) These differences are not 401 
clinically meaningful. Indeed, in this study, there was significant and clinically 402 
meaningful improvement in postoperative CDVA of 2 ½ to 3 lines, following surgery 403 
by either method. The improvement was similar in both groups, with the FLACS 404 
group gaining, on average, one logMAR letter more than the CPCS group. There 405 
was a difference in the proportion of patients with better, unchanged or worse 406 
postoperative CDVA, with the CPCS group performing better in these categories. 407 
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Multivariate regression analysis revealed that worse postoperative CDVA was 408 
associated with better preoperative CDVA, ocular co-morbidity, FLACS, posterior 409 
capsule opacification (PCO), uveitis and other postoperative complications. Given 410 
the fact that the two groups were exactly matched for preoperative CDVA, a possible 411 
reason why the FLACS group had more cases with worse postoperative CDVA than 412 
the CPCS group is the higher rate of postoperative complications.  413 
 414 
Postoperative complications including corneal oedema, early PCO reducing visual 415 
acuity, uveitis requiring treatment and uncontrolled intraocular pressure, were higher 416 
in the FLACS than the CPCS group. A study of 1105 FLACS eyes with 6 weeks 417 
follow-up, found similar rates of corneal oedema, and higher rates of posterior 418 
capsule opacification and raised intraocular pressure, than our study. (Chee 2015) 419 
Even though this study (Chee 2015) contained matched historical CPCS cases, a 420 
comparison of postoperative complications between groups was not done. The 421 
meta-analysis of nine randomized controlled trials, including 989 eyes (512 FLACS 422 
and 477 CPCS) found no difference in postoperative endothelial cell counts and 423 
central corneal thickness past the first day of follow-up and no difference in the rate 424 
of macular oedema and elevated intraocular pressure. (Chen 2015) Both intraocular 425 
surgery and the delivery of laser energy to intraocular tissues are pro-inflammatory, 426 
through disruption of the blood-aqueous barrier. Our data suggest that FLACS may 427 
be a little more pro-inflammatory than CPCS, leading to higher rates of corneal 428 
oedema, early PCO reducing visual acuity, uveitis requiring treatment and 429 
uncontrolled intraocular pressure. One prospective comparative study found that 430 
prostaglandin levels in the aqueous of patients increased following FLACS compared 431 
to CPCS. (Schultz 2013) However, in a prospective intra individual study of 204, the 432 
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levels of postoperative laser flare photometry as a measure of postoperative 433 
intraocular inflammation were higher 2 hours following the procedure, in the CPCS 434 
than in the FLACS group. (Conrad-Hengerer 2014b) The rates of postoperative 435 
complications in the CPCS group were low, compared to a previous EUREQUO-436 
based study. (Lundstrom 2012) 437 
 438 
Absolute BPE (also called mean absolute error) was 0.43D in the FLACS group and 439 
0.40D in the CPCS group, with the difference being statistically but not clinically 440 
significant. The percent of eyes within ± 0.5 D and within ± 1.0 D of target was higher 441 
in the CPCS than the FLACS group (74% versus 72% and 94% versus 92%, 442 
respectively). Multivariate regression analysis revealed that younger age, poor 443 
preoperative CDVA, previous corneal refractive surgery, ocular co-morbidity and 444 
FLACS was related to BPE outside ± 1D of target. The refractive outcomes of other 445 
studies comparing FLACS to CPCS are variable.  A prospective multicenter 446 
comparative cohort study of 1876 eyes (988 FLACS versus 888 CPCS) with 6 moths 447 
follow-up found that CPCS had better refractive results than FLACS (absolute BPE 448 
of 0.35 D versus 0.41D and 83% within ± 0.5 D versus 72%). (Ewe 2015) A 449 
nonrandomized cohort study of 1105 FLACS eyes with 420 matched, historical 450 
controls with 6 weeks follow-up, found no difference in the absolute BPE between 451 
the two groups (0.33 D versus 0.30 D). (Chee 2015) A prospective randomized intra 452 
individual cohort study of 200 eyes with 6 months follow-up found that in the FLACS 453 
group 92% and 100% of eyes were within ± 0.5 D and ± 1.0 D of target, respectively, 454 
the highest reported rates in the peer-reviewed literature to-date. (Conrad-Hengerer 455 
2015) Overall, the published refractive results for FLACS are very good and within 456 
the accepted benchmark standards for CPCS. (Lundstrom 2012) In our study, the 457 
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superior refractive results in the CPCS group could be explained by smaller 458 
proportion of eyes with previous corneal refractive surgery.  459 
 460 
Corneal astigmatism was considered clinically meaningful if the mean K was  0.25 461 
D, because this is the smallest amount that can be corrected by glasses or contact 462 
lenses. Cases that received FLACS corneal astigmatic treatment, were analyzed 463 
separately from FLACS cases that did not. When compared to CPCS cases, FLACS 464 
cases without corneal astigmatic treatment had similar preoperative astigmatism to 465 
CPCS cases (0.93 D versus 0.97 D). In contrast, FLACS cases that received corneal 466 
astigmatic treatment had much higher preoperative astigmatism (1.30 D). CPCS 467 
cases with high preoperative astigmatic treatment were not analyzed separately. 468 
Postoperative corneal astigmatism was statistically lower, but clinically similar in both 469 
FLACS and CPCS groups (0.89 D versus 0.95 D). In addition, corneal astigmatism 470 
did not change significantly following cataract surgery in either group, except in the 471 
FLACS subgroup that received corneal astigmatic treatment (1.30 D preoperatively 472 
and 0.87 D postoperatively). This represented 4.5% of all FLACS cases. Our results 473 
are very similar to a previous retrospective interventional case series of 54 eyes that 474 
underwent FLACS including corneal astigmatic treatment. (Chan 2015) In our study 475 
almost double the number of CPCS, compared to FLACS eyes had residual 476 
postoperative cylinder of 1.5 D or higher (18.4% versus 9.2%). Surgically induced 477 
astigmatism in the two groups was measured by the Naeser polar value at the 478 
surgical meridian, which indicates the power of the efficacy of the surgical procedure. 479 
(Naeser 1997) The Naeser polar value was smaller in the FLACS groups by 0.06 D. 480 
This difference increased to 0.1 D, when all cases that received a toric IOL, FLACS 481 
corneal astigmatic treatment or previous corneal refractive surgery were excluded.  482 
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 483 
There are limitations to this study. It is registry based, not a randomized controlled 484 
trial. FLACS is in its infancy whilst CPCS is tried and tested. There was no 485 
standardization of visual acuity testing, nor was there independent validation of 486 
entered data. The allocation to femto was at the discretion of the surgeon. We did 487 
not measure circularity or centration of the rhexis, effective lens position, or record 488 
the femto platform used, phacoemulsification energy used, endothelial cell counts. 489 
Although these parameters are relevant, but because there were no comparators in 490 
the EUREQUO database for matching, we could not include them in this study. 491 
 492 
In conclusion, in a case-control study in the real-life clinical setting, both FLACS and 493 
CPCS have excellent visual outcomes and low complications. This study dispels the 494 
claims that FLACS is a major advance and superior to the non-laser method. FLACS 495 
has superior astigmatic outcomes, whilst CPCS has slightly better visual outcomes. 496 
Intraoperative complications are similar and low in both groups. Postoperative 497 
complications are higher in the FLACS group and specifically the FLACS patients 498 
had a higher incidence of postoperative visual acuity worse than that prevailing 499 
preoperatively, due specifically to corneal edema, early PCO and uveitis requiring 500 
treatment. Future sophistication of FLACS may eliminate these differences. 501 
 502 
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